Back to results
CompletedPhase 1

Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production

NCT03852901

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

National Institute on Aging, Clinical Research Unit

Baltimore, Maryland, United States

View on ClinicalTrials.gov
Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production — TrialFind